Chunlizhengda Medical Instruments (1858.HK) - The Concerns and the Outlook After Losing the Bidding
173 Views27 Sep 2021 09:14
This article mainly analyzed Chunlizhengda in terms of the potential impact of losing the bidding on the hip joint prosthesis products, the alternative solutions, the concerns and the business outlook
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
Top 5%
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
- United Laboratories International Holdings Placement (3933.HK) - Valuation Pullback Seems Inevitable19 Sep 2023
- Chunlizhengda Medical Instruments (1858.HK/688236.CH) - 2023 Full-Year Results May Be Disappointing19 Sep 2023
- Chunlizhengda Medical Instruments (1858.HK) - Conservative About the Outlook12 Jan 2022
- Chunlizhengda Medical Instruments (1858.HK) - The Concerns and the Outlook After Losing the Bidding27 Sep 2021
- AK Medical Holdings Limited (1789.HK) - A Safe Landing After the Centralized Procurement22 Sep 2021
- China Healthcare Weekly (Sep17) - A New Round of Rebalancing, Artificial Joints VBP, Genetic Testing20 Sep 2021
- Pre-IPO Beijing Airdoc Technology - The Strength and the Concerns29 Jul 2021
x